Evolent Health, Inc. EVH Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 21.3%+6.9pp | 14.4%-9.1pp | 23.4%0.0pp | 23.4%-4.2pp | |
| Operating margin | -21.9%-20.3pp | -1.6%+2.0pp | -3.6%— | —— | |
| Net margin | -28.5%-26.1pp | -2.4%+3.3pp | -5.8%-4.3pp | -1.4%+2.7pp | |
| Returns | |||||
| Return on equity | -75.5%-69.5pp | -6%+5.8pp | -11.7%-9.3pp | -2.5%+3.3pp | |
| Return on invested capital | -28.6%-26.1pp | -2.6%+2.8pp | -5.3%-5.5pp | 0.2%+6.4pp | |
| Efficiency | |||||
| Asset turnover | 0.8×-0.1× | 1×+0.1× | 0.9×0.0× | 0.8×+0.2× | |
| Liquidity | |||||
| Current ratio | 1.3×+0.5× | 0.8×-0.2× | 1×-0.1× | 1.1×-0.1× | |
| Leverage | |||||
| Debt-to-equity | 2.4×+1.7× | 0.7×+0.1× | 0.6×0.0× | 0.6×+0.1× | |
| Per Share | |||||
| Book value per share | $3.64-58.4% | $8.73-9.0% | $9.60+4.6% | $9.17+13.8% | |
| Valuation | |||||
| Market capitalization | $565.78M-47.9% | $1.29B-65.9% | $3.8B+33.6% | $2.84B+14.9% | |
| Price / sales | 0.3×-0.2× | 0.5×-1.4× | 1.9×-0.2× | 2.1×-0.6× | |
| Price / book | 1.4×+0.3× | 1.3×-2.3× | 3.6×+0.3× | 3.3×-0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Evolent Health, Inc.'s profit margins?
- Evolent Health, Inc. (EVH) runs a 20.2% gross margin and a -22.2% operating margin, with a -26.3% net margin.
- Where do Evolent Health, Inc.'s ratios come from?
- Every ratio is computed from Evolent Health, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
